Expression of Hypoxia Inducible Factor 2 Alpha and Its Clinical Significance in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization

SUN Haixiang,YANG Xinrong,XU Yang,FAN Jia
DOI: https://doi.org/10.3969/j.issn.1008-6358.2013.01.003
2013-01-01
Abstract:Objective:To investigate the expression of hypoxia inducible factor 2 alpha(HIF-2α) and its clinical significance in patients with hepatocellular carcinoma treated with transarterial chemoembolization(TACE).Methods:HIF-2α mRNA and protein levels were detected by quantitative real-time reverse transcription polymerase chain reaction and Western blot in the tissues of hepatocellular carcinoma from patients underwent TACE and operation(study group,n=30) and patients merely underwent operation(control group,n=30).Expression of HIF-2α was further studied using immunohistochemistry.Finally,the clinical significance of HIF-2α was analyzed.Results: Expression levels of HIF-2α mRNA and protein were significantly up-regulated in the study group compared with those in the control group(P0.05).The level of HIF-2α protein was significantly correlated with overall survival(95 % confidence interval: 0.442~0.972,P0.05),but not correlated with disease-free survival(P0.05) in patients with hepatocellular carcinoma.Conclusions: TACE treatment significantly increases HIF-2α expression level,and the level of HIF-2α is correlated with malignant phenotypes of hepatocellular carcinoma.
What problem does this paper attempt to address?